A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4545 (2006.01) A61K 31/19 (2006.01) A61K 31/40 (2006.01) A61K 31/519 (2006.01) A61K 31/551 (2006.01) A61K 31/554 (2006.01) A61P 25/08 (2006.01) A61P 25/18 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2668384
The side effect leading to overweight or obesity in medication with a known antipsychotic, antidepressant or antiepileptic drug is reduced by the administration of O-(3- piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime or a pharmaceutically acceptable acid addition salt thereof.
Le surpoids ou l'obésité apparaissant comme effet secondaire connu d'une médication antipsychotique, antidépressive ou un anti-épileptique est réduit par l'administration d'amidoxine O-(3- pipéridino-2-hydroxy-1-propyl)-nicotinique ou d'un sel d'addition d'acides pharmaceutiquement acceptable de celui-ci.
Balogh Gabor
Bernath Sandor
Brownstein Mike
Egri Janos
Kolonics Attila
Fetherstonhaugh & Co.
N-Gene Research Laboratories Inc.
LandOfFree
A pharmaceutical composition having antipsychotic,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A pharmaceutical composition having antipsychotic,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A pharmaceutical composition having antipsychotic,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1550824